Insider · CIK 0001966716
Jonathan Allan
Files at STOK (Stoke Therapeutics, Inc.). First filing Dec 10, 2024, latest Oct 2, 2026.
In brief
Jonathan Allan files SEC Form 4 as officer at STOK (Stoke Therapeutics, Inc.). Since Dec 10, 2024, Jonathan Allan has reported 0 open-market buys worth $0 and 15 open-market sells worth $2.6M, the latest filed on Oct 2, 2026.
A track record needs three past buys with six months of prices behind them; Jonathan Allan has 0, so none is measured yet.
The newest scored trade: sold $17k of STOK on Oct 2, 2026, filed Oct 2, 2026, scored 3 (weak), under a 10b5-1 plan. In the last 12 months: 0 buys worth $0 and 8 sells worth $1.3M.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
STOK: Stoke Therapeutics, Inc.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 3Weak | Stoke Therapeutics, Inc. | $17k 627 shares | -3% | +15% from low-33% from high | |
| 29Weak | Stoke Therapeutics, Inc. | $92k 2,861 shares | -12% | +74% from low-16% from high | |
| 1Weak | Stoke Therapeutics, Inc. | $44k 1,457 shares | -7% | +157% from low-24% from high | |
| 34Weak | Stoke Therapeutics, Inc. | $313k 9,293 shares | -32% | +468% from low-13% from high | |
| 49Moderate | Stoke Therapeutics, Inc. | $286k 8,895 shares | -24% | +457% from low-14% from high | |
| 31Weak | Stoke Therapeutics, Inc. | $128k 3,978 shares | -25% | +459% from low-7% from high | |
| 19Weak | Stoke Therapeutics, Inc. | $306k 9,803 shares | -38% | +426% from low-13% from high | |
| 31Weak | Stoke Therapeutics, Inc. | $138k 4,576 shares | -19% | +405% from low-16% from high | |
| 18Weak | Stoke Therapeutics, Inc. | $251k 10,000 shares | -46% | +333% from low0% from high | |
| 32Weak | Stoke Therapeutics, Inc. | $445k 22,117 shares | -89% | +235% from low-0% from high | |
| 35Weak | Stoke Therapeutics, Inc. | $31k 1,683 shares | -7% | +214% from low0% from high | |
| 32Weak | Stoke Therapeutics, Inc. | $206k 13,712 shares | -41% | +187% from low0% from high | |
| 34Weak | Stoke Therapeutics, Inc. | $36k 4,211 shares | -12% | +20% from low-42% from high | |
| 32Weak | Stoke Therapeutics, Inc. | $186k 13,666 shares | -39% | +22% from low-10% from high | |
| 45Moderate | Stoke Therapeutics, Inc. | $124k 9,696 shares | -22% | +18% from low-13% from high |
Planned sales
Form 144 notices this insider filed before selling restricted or control stock, newest first.
| Filed | Company | Shares | Value | Sale date | Past 3 months |
|---|---|---|---|---|---|
| Oct 2, 2026 | STOK Stoke Therapeutics, Inc. | 627 0.00% of outstanding | $16k | Oct 2, 2026 | $92k |
| Jun 16, 2026 | STOK STOKE THERAPEUTICS INC | 1,457 0.00% of outstanding | $44k | Jun 16, 2026 | $912k |
| Mar 20, 2026 | STOK STOKE THERAPEUTICS INC | 9,293 0.02% of outstanding | $308k | Mar 20, 2026 | $286k |
| Dec 8, 2025 | STOK STOKE THERAPEUTICS INC | 3,978 0.01% of outstanding | $123k | Dec 8, 2025 | $695k |
| Dec 5, 2025 | STOK STOKE THERAPEUTICS INC | 7,781 0.01% of outstanding | $242k | Dec 5, 2025 | $389k |
| Oct 3, 2025 | STOK STOKE THERAPEUTICS INC | 10,000 0.02% of outstanding | $248k | Oct 3, 2025 | $681k |
| Aug 29, 2025 | STOK STOKE THERAPEUTICS INC | 22,117 0.04% of outstanding | $437k | Aug 29, 2025 | $236k |
| Aug 13, 2025 | STOK STOKE THERAPEUTICS INC | 13,712 0.03% of outstanding | $186k | Aug 13, 2025 | none |
| Dec 9, 2024 | STOK STOKE THERAPEUTICS INC | 12,114 0.02% of outstanding | $161k | Dec 9, 2024 | none |
Transactions
The newest 50 of 67 rows this insider has filed.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Oct 2, 2026 | STOK Stoke Therapeutics, Inc. | SOpen-market sale Common Stock10b5-1 | -627 | $26.33 | $17k | 20,598 | 11 d ago |
| Aug 14, 2026 | STOK Stoke Therapeutics, Inc. | MOption exercise Common Stock | +6,000 | $0.00 | $0 | 24,086 | Aug 18, 2026 |
| Aug 18, 2026 | STOK Stoke Therapeutics, Inc. | SOpen-market sale Common Stock | -2,716 | $32.01 | $87k | 21,370 | Aug 18, 2026 |
| Aug 18, 2026 | STOK Stoke Therapeutics, Inc. | SOpen-market sale Common Stock | -145 | $32.47 | $4,708 | 21,225 | Aug 18, 2026 |
| Aug 14, 2026 | STOK Stoke Therapeutics, Inc. | MOption exercise Performance Stock Unitsderivative | -6,000 | $0.00 | $0 | 0 | Aug 18, 2026 |
| Jun 16, 2026 | STOK Stoke Therapeutics, Inc. | SOpen-market sale Common Stock10b5-1 | -1,457 | $29.95 | $44k | 18,086 | Jun 18, 2026 |
| Mar 20, 2026 | STOK Stoke Therapeutics, Inc. | SOpen-market sale Common Stock10b5-1 | -8,692 | $33.64 | $292k | 20,144 | Mar 24, 2026 |
| Mar 20, 2026 | STOK Stoke Therapeutics, Inc. | SOpen-market sale Common Stock10b5-1 | -601 | $34.41 | $21k | 19,543 | Mar 24, 2026 |
| Mar 17, 2026 | STOK Stoke Therapeutics, Inc. | SOpen-market sale Common Stock | -2,476 | $32.74 | $81k | 35,255 | Mar 19, 2026 |
| Mar 17, 2026 | STOK Stoke Therapeutics, Inc. | SOpen-market sale Common Stock | -1,791 | $33.38 | $60k | 33,464 | Mar 19, 2026 |
| Mar 18, 2026 | STOK Stoke Therapeutics, Inc. | SOpen-market sale Common Stock | -4,222 | $31.28 | $132k | 29,242 | Mar 19, 2026 |
| Mar 18, 2026 | STOK Stoke Therapeutics, Inc. | SOpen-market sale Common Stock | -334 | $31.79 | $11k | 28,908 | Mar 19, 2026 |
| Mar 18, 2026 | STOK Stoke Therapeutics, Inc. | SOpen-market sale Common Stock | -72 | $32.85 | $2,365 | 28,836 | Mar 19, 2026 |
| Mar 15, 2026 | STOK Stoke Therapeutics, Inc. | MOption exercise Common Stock | +7,475 | $0.00 | $0 | 19,731 | Mar 17, 2026 |
| Mar 15, 2026 | STOK Stoke Therapeutics, Inc. | MOption exercise Common Stock | +6,000 | $0.00 | $0 | 25,731 | Mar 17, 2026 |
| Mar 15, 2026 | STOK Stoke Therapeutics, Inc. | MOption exercise Common Stock | +12,000 | $0.00 | $0 | 37,731 | Mar 17, 2026 |
| Mar 15, 2026 | STOK Stoke Therapeutics, Inc. | MOption exercise Restricted Stock Unitsderivative | -7,475 | $0.00 | $0 | 7,475 | Mar 17, 2026 |
| Mar 15, 2026 | STOK Stoke Therapeutics, Inc. | MOption exercise Restricted Stock Unitsderivative | -6,000 | $0.00 | $0 | 12,000 | Mar 17, 2026 |
| Mar 15, 2026 | STOK Stoke Therapeutics, Inc. | MOption exercise Restricted Stock Unitsderivative | -12,000 | $0.00 | $0 | 36,000 | Mar 17, 2026 |
| Feb 17, 2026 | STOK Stoke Therapeutics, Inc. | AGrant or award Employee Stock Option (Right to Buy)derivative | +53,000 | $0.00 | $0 | 53,000 | Feb 19, 2026 |
| Feb 17, 2026 | STOK Stoke Therapeutics, Inc. | AGrant or award Restricted Stock Unitsderivative | +35,000 | $0.00 | $0 | 35,000 | Feb 19, 2026 |
| Dec 8, 2025 | STOK Stoke Therapeutics, Inc. | SOpen-market sale Common Stock10b5-1 | -1,300 | $31.60 | $41k | 14,509 | Dec 10, 2025 |
| Dec 8, 2025 | STOK Stoke Therapeutics, Inc. | SOpen-market sale Common Stock10b5-1 | -2,678 | $32.61 | $87k | 11,831 | Dec 10, 2025 |
| Dec 3, 2025 | STOK Stoke Therapeutics, Inc. | MOption exercise Common Stock10b5-1 | +6,000 | $0.00 | $0 | 25,612 | Dec 5, 2025 |
| Dec 4, 2025 | STOK Stoke Therapeutics, Inc. | SOpen-market sale Common Stock10b5-1 | -824 | $30.76 | $25k | 24,788 | Dec 5, 2025 |
| Dec 4, 2025 | STOK Stoke Therapeutics, Inc. | SOpen-market sale Common Stock10b5-1 | -194 | $31.32 | $6,075 | 24,594 | Dec 5, 2025 |
| Dec 5, 2025 | STOK Stoke Therapeutics, Inc. | SOpen-market sale Common Stock10b5-1 | -1,004 | $31.33 | $31k | 23,590 | Dec 5, 2025 |
| Dec 5, 2025 | STOK Stoke Therapeutics, Inc. | SOpen-market sale Common Stock10b5-1 | -5,437 | $31.08 | $169k | 18,153 | Dec 5, 2025 |
| Dec 5, 2025 | STOK Stoke Therapeutics, Inc. | SOpen-market sale Common Stock10b5-1 | -2,344 | $31.76 | $74k | 15,809 | Dec 5, 2025 |
| Dec 3, 2025 | STOK Stoke Therapeutics, Inc. | MOption exercise Performance Stock Unitsderivative10b5-1 | -6,000 | $0.00 | $0 | 0 | Dec 5, 2025 |
| Dec 1, 2025 | STOK Stoke Therapeutics, Inc. | MOption exercise Common Stock | +12,357 | $0.00 | $0 | 24,188 | Dec 3, 2025 |
| Dec 2, 2025 | STOK Stoke Therapeutics, Inc. | SOpen-market sale Common Stock | -1,416 | $29.56 | $42k | 22,772 | Dec 3, 2025 |
| Dec 2, 2025 | STOK Stoke Therapeutics, Inc. | SOpen-market sale Common Stock | -868 | $30.14 | $26k | 21,904 | Dec 3, 2025 |
| Dec 3, 2025 | STOK Stoke Therapeutics, Inc. | SOpen-market sale Common Stock | -898 | $30.34 | $27k | 21,006 | Dec 3, 2025 |
| Dec 3, 2025 | STOK Stoke Therapeutics, Inc. | SOpen-market sale Common Stock | -1,394 | $30.85 | $43k | 19,612 | Dec 3, 2025 |
| Dec 1, 2025 | STOK Stoke Therapeutics, Inc. | MOption exercise Restricted Stock Unitsderivative | -12,357 | $0.00 | $0 | 0 | Dec 3, 2025 |
| Oct 3, 2025 | STOK Stoke Therapeutics, Inc. | MOption exercise Common Stock10b5-1 | +10,000 | $9.15 | $92k | 21,831 | Oct 7, 2025 |
| Oct 3, 2025 | STOK Stoke Therapeutics, Inc. | SOpen-market sale Common Stock10b5-1 | -10,000 | $25.07 | $251k | 11,831 | Oct 7, 2025 |
| Oct 3, 2025 | STOK Stoke Therapeutics, Inc. | MOption exercise Stock Option (Right to Buy)derivative10b5-1 | -10,000 | $0.00 | $0 | 34,800 | Oct 7, 2025 |
| Aug 29, 2025 | STOK Stoke Therapeutics, Inc. | MOption exercise Common Stock10b5-1 | +850 | $7.07 | $6,010 | 24,798 | Sep 3, 2025 |
| Aug 29, 2025 | STOK Stoke Therapeutics, Inc. | SOpen-market sale Common Stock10b5-1 | -850 | $20.00 | $17k | 23,948 | Sep 3, 2025 |
| Sep 2, 2025 | STOK Stoke Therapeutics, Inc. | MOption exercise Common Stock10b5-1 | +9,150 | $7.07 | $65k | 33,098 | Sep 3, 2025 |
| Sep 2, 2025 | STOK Stoke Therapeutics, Inc. | SOpen-market sale Common Stock10b5-1 | -14,922 | $20.14 | $300k | 18,176 | Sep 3, 2025 |
| Sep 3, 2025 | STOK Stoke Therapeutics, Inc. | SOpen-market sale Common Stock10b5-1 | -6,345 | $20.07 | $127k | 11,831 | Sep 3, 2025 |
| Aug 29, 2025 | STOK Stoke Therapeutics, Inc. | MOption exercise Stock Option (Right to Buy)derivative10b5-1 | -850 | $0.00 | $0 | 24,951 | Sep 3, 2025 |
| Sep 2, 2025 | STOK Stoke Therapeutics, Inc. | MOption exercise Stock Option (Right to Buy)derivative10b5-1 | -9,150 | $0.00 | $0 | 15,801 | Sep 3, 2025 |
| Aug 18, 2025 | STOK Stoke Therapeutics, Inc. | SOpen-market sale Common Stock | -1,683 | $18.24 | $31k | 23,948 | Aug 20, 2025 |
| Aug 14, 2025 | STOK Stoke Therapeutics, Inc. | MOption exercise Common Stock | +6,000 | $0.00 | $0 | 25,631 | Aug 18, 2025 |
| Aug 14, 2025 | STOK Stoke Therapeutics, Inc. | AGrant or award Performance Stock Unitsderivative | +12,000 | $0.00 | $0 | 12,000 | Aug 18, 2025 |
| Aug 14, 2025 | STOK Stoke Therapeutics, Inc. | MOption exercise Performance Stock Unitsderivative | -6,000 | $0.00 | $0 | 6,000 | Aug 18, 2025 |
Questions about Jonathan Allan
Answered from the filings on this page, as of the latest one.
Is Jonathan Allan buying or selling?
In the last 12 months Jonathan Allan reported 0 open-market buys worth $0 and 8 open-market sells worth $1.3M on SEC Form 4; the latest was sold $17k of STOK on Oct 2, 2026. Grants, option exercises and tax withholding are not counted.
How did Jonathan Allan's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Jonathan Allan has 0.
Where does Jonathan Allan file Form 4?
Jonathan Allan has filed Form 4 at STOK (Stoke Therapeutics, Inc.) as GENERAL COUNSEL & CORP SEC. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.